HER2/neu Receptor Antagonist [EPC] - N0000175661

Pharmacologic Code	N0000175661
Pharmacologic Name	HER2/neu Receptor Antagonist
Pharmacologic Uses	HER2/neu receptor antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 14 products whose active ingredient are classified under the same pharmacologic class HER2/neu Receptor Antagonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0069-0308	Trazimera	Non-Proprietary Name: Trastuzumab-qyyp	Injection, Powder, Lyophilized, For Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	50242-077	Herceptin Hylecta	Non-Proprietary Name: Trastuzumab And Hyaluronidase-oysk	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-132	Herceptin	Non-Proprietary Name: Trastuzumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-145	Perjeta	Non-Proprietary Name: Pertuzumab	Injection, Solution, Concentrate	Intravenous	Genentech, Inc.	ACTIVE
	50242-245	Phesgo	Non-Proprietary Name: Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-260	Phesgo	Non-Proprietary Name: Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	55513-132	Kanjinti	Non-Proprietary Name: Trastuzumab-anns	Injection, Powder, Lyophilized, For Solution	Intravenous	Amgen Inc	ACTIVE
	55513-141	Kanjinti	Non-Proprietary Name: Trastuzumab-anns	Injection, Powder, Lyophilized, For Solution	Intravenous	Amgen Inc	ACTIVE
	63459-303	Herzuma	Non-Proprietary Name: Trastuzumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Cephalon, Inc.	ACTIVE
	67457-991	Ogivri	Non-Proprietary Name: Trastuzumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Mylan Institutional Llc	ACTIVE
	74527-022	Margenza	Non-Proprietary Name: Margetuximab-cmkb	Injection, Solution, Concentrate	Intravenous	Macrogenics, Inc	ACTIVE
	78206-147	Ontruzant	Non-Proprietary Name: Trastuzumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Organon Llc	ACTIVE
	83257-001	Ogivri	Non-Proprietary Name: Trastuzumab-dkst	Injection, Powder, Lyophilized, For Solution	Intravenous	Biocon Biologics Inc.	ACTIVE
	83257-003	Ogivri	Non-Proprietary Name: Trastuzumab-dkst	Injection, Powder, Lyophilized, For Solution	Intravenous	Biocon Biologics Inc.	ACTIVE